Nω-hydroxy-L-arginine hornologues and hydroxylarnine as nitric oxide-dependent vasorelaxant agents

被引:15
作者
Beranova, P
Chalupsky, K
Kleschyov, AL
Schott, C
Boucher, JL
Mansuy, D
Munzel, T
Muller, B
Stoclet, JC
机构
[1] CNRS, Illkirch Graffenstaden, France
[2] Univ Strasbourg 1, UMR 7034, Illkirch Graffenstaden, France
[3] Univ Mainz, Dept Med 2, D-6500 Mainz, Germany
[4] CNRS, Lab Pharmacol & Toxicol Biochem, Paris, France
[5] Univ Paris 05, UMR 8601, Paris, France
关键词
N-omega-hydroxy-L-arginine homologue; hydroxylamine; nitric oxide release; vasorelaxation; electron paramagnetic resonance;
D O I
10.1016/j.ejphar.2005.04.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endothelium-independent relaxant activities of A N-omega-hydroxy-L-arginine (L-NOHA) homologues and hydroxylamine, a possible intermediate in nitric oxide (NO) formation, were examined in rat aortic rings. Addition of one -CH2- group to the -(CH2)(x)- chain between the a-amino acid and the hydroxyguanidine group (x=4) almost abolished-while deletion of one or two -CH2-(x=1 or 2) enhanced-the relaxant activity of L-NOHA homologues. N-omega-hydroxy-nor-L-arginine- (x=2) and hydroxylamine-induced relaxations were blunted by a NO scavenger and by inhibitors of the guanylyl cyclase pathway, but not by NO synthase or cytochrome P-450 inhibitors (except 7-ethoxyresorufin). However, aortic NO fort-nation was detected (using electron paramagnetic resonance) in the presence of concentrations of these compounds higher than those producing relaxation. These findings support the view that endothelium-independent vasorelaxations induced by both L-NOHA homologues with a required chain length x <= 3 and hydroxylamine are mediated by NO-dependent activation of guanylyt cyclase, through a 7-ethoxyresorufin-inhibited mechanism. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:260 / 267
页数:8
相关论文
共 34 条
  • [1] Mechanisms mediating the vasodilatory effects of N-hydroxy-L-arginine in coronary arteries
    AbdulHussain, MN
    Jia, YL
    Hussain, SNA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 305 (1-3) : 155 - 161
  • [2] Baggio R, 1999, J PHARMACOL EXP THER, V290, P1409
  • [3] Inhibition of Mn-2(2+)-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid
    Baggio, R
    Elbaum, D
    Kanyo, ZF
    Carroll, PJ
    Cavalli, RC
    Ash, DE
    Christianson, DW
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (34) : 8107 - 8108
  • [4] FORMATION OF NITROGEN-OXIDES AND CITRULLINE UPON OXIDATION OF N-OMEGA-HYDROXY-L-ARGININE BY HEMEPROTEINS
    BOUCHER, JL
    GENET, A
    VADON, S
    DELAFORGE, M
    MANSUY, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) : 1158 - 1164
  • [5] N-OMEGA-HYDROXY-L-ARGININE, AN INTERMEDIATE IN THE L-ARGININE TO NITRIC-OXIDE PATHWAY, IS A STRONG INHIBITOR OF LIVER AND MACROPHAGE ARGINASE
    BOUCHER, JL
    CUSTOT, J
    VADON, S
    DELAFORGE, M
    LEPOIVRE, M
    TENU, JP
    YAPO, A
    MANSUY, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (03) : 1614 - 1621
  • [6] Oxidation of the ketoxime acetoxime to nitric oxide by oxygen radical-generating systems
    Caro, AA
    Cederbaum, AL
    Stoyanovsky, DA
    [J]. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2001, 5 (04): : 413 - 424
  • [7] Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle
    Chalupsky, K
    Lobysheva, I
    Nepveu, F
    Gadea, I
    Beranova, P
    Entlicher, G
    Stoclet, JC
    Muller, B
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 67 (06) : 1203 - 1214
  • [8] CORREIRA NA, 2000, LIFE SCI, V66, P709
  • [9] CRAVEN PA, 1979, J BIOL CHEM, V254, P8213
  • [10] HYDROXYLAMINE IS A VASORELAXANT AND A POSSIBLE INTERMEDIATE IN THE OXIDATIVE CONVERSION OF L-ARGININE TO NITRIC-OXIDE
    DEMASTER, EG
    RAIJ, L
    ARCHER, SL
    WEIR, EK
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 163 (01) : 527 - 533